These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26445283)

  • 1. Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064.
    Chen I; Clarke W; Ou SS; Marzinke MA; Breaud A; Emel LM; Wang J; Hughes JP; Richardson P; Haley DF; Lucas J; Rompalo A; Justman JE; Hodder SL; Eshleman SH
    PLoS One; 2015; 10(10):e0140074. PubMed ID: 26445283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043).
    Fogel JM; Clarke W; Kulich M; Piwowar-Manning E; Breaud A; Olson MT; Marzinke MA; Laeyendecker O; Fiamma A; Donnell D; Mbwambo JK; Richter L; Gray G; Sweat M; Coates TJ; Eshleman SH; Chingono AH
    J Acquir Immune Defic Syndr; 2017 Feb; 74(2):158-165. PubMed ID: 27828875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural control of HIV infection in young women in South Africa: HPTN 068.
    Sivay MV; Fogel JM; Wang J; Zhang Y; Piwowar-Manning E; Clarke W; Breaud A; Blankson J; Hamilton EL; Kahn K; Selin A; Gomez-Olive FX; MacPhail C; Hughes JP; Pettifor A; Eshleman SH
    HIV Clin Trials; 2018 Oct; 19(5):202-208. PubMed ID: 30522410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART).
    Grant-McAuley W; Piwowar-Manning E; Clarke W; Breaud A; Zewdie KB; Moore A; Ayles HM; Kosloff B; Shanaube K; Bock P; Meehan SA; Maarman G; Fidler S; Hayes R; Donnell D; Eshleman SH;
    J Int AIDS Soc; 2023 Oct; 26(10):e26179. PubMed ID: 37886843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART).
    Fogel JM; Wilson EA; Piwowar-Manning E; Breaud A; Clarke W; Petropoulos C; Moore A; Fraser C; Kosloff B; Shanaube K; van Zyl G; Scheepers M; Floyd S; Bock P; Ayles H; Fidler S; Hayes R; Donnell D; Eshleman SH;
    J Int AIDS Soc; 2022 Jul; 25(7):e25941. PubMed ID: 35775502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undisclosed antiretroviral drug use in Botswana: implication for national estimates.
    Moyo S; Gaseitsiwe S; Powis KM; Pretorius Holme M; Mohammed T; Zahralban-Steele M; Yankinde EK; Maphorisa C; Abrams W; Lebelonyane R; Manyake K; Sekoto T; Mmalane M; Gaolathe T; Wirth KE; Makhema J; Lockman S; Clarke W; Essex M; Novitsky V
    AIDS; 2018 Jul; 32(11):1543-1546. PubMed ID: 29762166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiretroviral drugs for prevention of HIV-mother-to-child transmission on hematological parameters and hemoglobin synthesis in HIV-uninfected newborns with and without thalassemia carrier.
    Wongnoi R; Oberdorfer P; Sirivatanapa P; Phanpong C; Pornprasert S
    Curr HIV Res; 2013 Apr; 11(3):187-92. PubMed ID: 23607655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania.
    Mosha F; Urassa W; Aboud S; Lyamuya E; Sandstrom E; Bredell H; Williamson C
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):377-82. PubMed ID: 20954839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viro-immunological response and emergence of resistance in HIV-infected women receiving combination antiretroviral regimens for the prevention of mother-to-child transmission in Malawi.
    Palombi L; Galluzzo CM; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Luhanga R; Mancinelli S; Ceffa S; Amici R; Marazzi MC; Vella S; Giuliano M
    J Antimicrob Chemother; 2014 Mar; 69(3):749-52. PubMed ID: 24135952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
    Little SJ; Daar ES; D'Aquila RT; Keiser PH; Connick E; Whitcomb JM; Hellmann NS; Petropoulos CJ; Sutton L; Pitt JA; Rosenberg ES; Koup RA; Walker BD; Richman DD
    JAMA; 1999 Sep 22-29; 282(12):1142-9. PubMed ID: 10501117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
    Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
    Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
    Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT;
    J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
    Kesho Bora Study Group
    Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study.
    Pacheco SE; McIntosh K; Lu M; Mofenson LM; Diaz C; Foca M; Frederick M; Handelsman E; Hayani K; Shearer WT;
    J Infect Dis; 2006 Oct; 194(8):1089-97. PubMed ID: 16991083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand.
    Apisarnthanarak A; Jirayasethpong T; Sa-nguansilp C; Thongprapai H; Kittihanukul C; Kamudamas A; Tungsathapornpong A; Mundy LM
    HIV Med; 2008 May; 9(5):322-5. PubMed ID: 18400079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-drug interactions: antiretroviral drugs and recreational drugs.
    Staltari O; Leporini C; Caroleo B; Russo E; Siniscalchi A; De Sarro G; Gallelli L
    Recent Pat CNS Drug Discov; 2014; 9(3):153-63. PubMed ID: 25429704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ongoing Maternal-Child Transmission of HIV in an Urban Area, 2003-2012.
    Rutstein RM; Volkman KM; Bonda S; Shah SS
    Hosp Pediatr; 2015 Feb; 5(2):92-5. PubMed ID: 25646202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.